| Q45098531 | A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adrenomedullary chromaffin vesicle |
| Q36605288 | Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias |
| Q33609371 | Biodegradable poly(ethylene glycol) hydrogels based on a self-elimination degradation mechanism |
| Q33226256 | Cloning and molecular characterization of the basic peroxidase isoenzyme from Zinnia elegans, an enzyme involved in lignin biosynthesis |
| Q94503762 | Computational Studies on the Mechanisms of Nonenzymatic Intramolecular Cyclization of the Glutamine Residues Located at N-Termini Catalyzed by Inorganic Phosphate Species |
| Q24532111 | Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation |
| Q38885729 | Crystallization and preliminary X-ray diffraction studies of the glutaminyl cyclase from Carica papaya latex |
| Q34995785 | Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms |
| Q30318462 | Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development |
| Q36584626 | Glutaminyl cyclases as novel targets for the treatment of septic arthritis |
| Q36520394 | High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli |
| Q24801065 | Human glutaminyl cyclase and bacterial zinc aminopeptidase share a common fold and active site |
| Q36221439 | Identification and Epigenetic Analysis of a Maternally Imprinted Gene Qpct |
| Q53397291 | Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation. |
| Q35197124 | Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease |
| Q28537855 | Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo |
| Q37086364 | Molecular characterization of tick salivary gland glutaminyl cyclase |
| Q30313757 | Natural Products from Microalgae with Potential against Alzheimer's Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors |
| Q28550956 | Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications |
| Q36038814 | Novel approach to inhibiting chemokine function |
| Q34087163 | Novel peptides from adrenomedullary chromaffin vesicles |
| Q36874127 | Oxidative folding and N-terminal cyclization of onconase |
| Q34243914 | PYROGLUTAMATE FORMATION AT THE N-TERMINI OF ABRI MOLECULES IN FAMILIAL BRITISH DEMENTIA IS NOT RESTRICTED TO THE CENTRAL NERVOUS SYSTEM |
| Q33288645 | Post-translational modifications of the basic peroxidase isoenzyme from Zinnia elegans. |
| Q33451302 | Primary structure and functional expression of a glutaminyl cyclase |
| Q43094963 | Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase |
| Q28575516 | Role of pGlu-serpinin, a novel chromogranin A-derived peptide in inhibition of cell death |
| Q37689616 | Stability of protein pharmaceuticals: an update |
| Q24338927 | Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding |
| Q28239988 | The association of common polymorphisms in the QPCT gene with bone mineral density in the Chinese population |
| Q35689622 | The chromogranins A and B: the first 25 years and future perspectives |
| Q30730238 | The enterins: a novel family of neuropeptides isolated from the enteric nervous system and CNS of Aplysia. |
| Q40651999 | The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease |
| Q36079389 | The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens |
| Q60891546 | The structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders |
| Q37165975 | The ups and downs of thyrotropin-releasing hormone |